Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Kenvue, Inc. ( (KVUE) ) has provided an announcement.
On January 29, 2026, Kenvue held a virtual special meeting at which approximately 78% of outstanding shares were represented, and about 99% of votes cast approved its previously announced merger agreement with Kimberly-Clark, clearing a key shareholder hurdle for the transaction. On the same day, Kimberly-Clark and Kenvue reported that roughly 96% of shares present at Kimberly-Clark’s own special meeting backed the issuance of Kimberly-Clark stock needed to complete the acquisition, marking a major milestone toward creating a larger global health and wellness player and signaling strong investor support for the deal, which now primarily hinges on regulatory approvals and customary closing conditions expected to be satisfied in the second half of 2026.
The most recent analyst rating on (KVUE) stock is a Hold with a $21.00 price target. To see the full list of analyst forecasts on Kenvue, Inc. stock, see the KVUE Stock Forecast page.
Spark’s Take on KVUE Stock
According to Spark, TipRanks’ AI Analyst, KVUE is a Neutral.
KVUE scores in the mid-range primarily due to solid profitability and strong free cash flow growth, tempered by weaker recent revenue trends and rising leverage. Technicals are mildly positive short term but constrained by trading below the 200-day average, while valuation is supported by a high dividend yield but moderated by a ~23 P/E. The pending merger is a positive catalyst, offset by related legal and closing-risk overhang.
To see Spark’s full report on KVUE stock, click here.
More about Kenvue, Inc.
Kenvue Inc. is the world’s largest pure-play consumer health company by revenue, built on more than a century of heritage and focused on science-backed, over-the-counter and personal care brands such as Aveeno, BAND-AID Brand, Johnson’s, Listerine, Neutrogena and Tylenol, which are widely recommended by healthcare professionals and positioned as everyday consumer essentials worldwide.
Average Trading Volume: 44,379,233
Technical Sentiment Signal: Sell
Current Market Cap: $33.53B
For an in-depth examination of KVUE stock, go to TipRanks’ Overview page.